Spero Therapeutics COO Timothy Keutzer Sells Shares Amid Market Volatility

Spero Therapeutics, Inc. (SPRO) has recently disclosed that Chief Operating Officer Keutzer Timothy has executed a series of transactions involving the sale of shares. On February 2, 2026, Timothy sold 18,891 shares at a price of $2.2 per share. On February 3, 2026, he sold an additional 24,224 shares at a price of $2.14 per share. Finally, on February 4, 2026, Timothy sold 3,471 shares at a price of $2.24 per share. These transactions have been reported in accordance with the company's obligations under applicable securities laws.